Top Markets
Coin of the day
Altamira Therapeutics Ltd. Altamira Therapeutics Ltd.

Altamira Therapeutics Ltd.

CYTO
Κατάταξη σε μετοχές #38206
Altamira Therapeutics Ltd. is a biotechnology firm dedicated to pioneering new... Altamira Therapeutics Ltd. is a biotechnology firm dedicated to pioneering new treatments for critical medical needs that are currently underserved. Its marketed offerings include Bentrio, a non-pharmaceutical nasal spray designed for individual protection against prevalent airborne viruses and allergens. The company is also heavily invested in developing RNA therapeutics specifically for extrahepatic targets. This includes their preclinical OligoPhore and SemaPhore platforms, engineered for the effective delivery of oligonucleotides and mRNA. In its clinical-stage portfolio, AM-125 is undergoing Phase II trials for the intranasal treatment of vertigo. Additionally, Keyzilen and Sonsuvi are both in Phase III clinical development; Keyzilen is focused on acute inner ear tinnitus, and Sonsuvi addresses acute inner ear hearing loss. Established in 2003 and headquartered in Hamilton, Bermuda, Altamira Therapeutics conducts operations across Switzerland, the United States, Europe, and Australia. The company officially adopted the name Altamira Therapeutics Ltd. in July 2021, prior to which it was known as Auris Medical Holding Ltd.
Τιμή μετοχής
$0.3
Τελευταίος συγχρονισμός: 2026-02-10
Κεφαλαιοποίηση
$1.13M
Αλλαγή (1 ημέρα)
0.00%
Αλλαγή (1 έτος)
328.57%
Χώρα
BM
Εμπόριο Altamira Therapeutics Ltd. (CYTO)

Κατηγορία

Ιστορικό τιμής μετοχής για την Altamira Therapeutics Ltd. (CYTO)
Υψηλότερη τιμή κλεισίματος: $0.30 στις 2026-02-01

Χαμηλότερη τιμή κλεισίματος: $502.51K στις 2014-08-01
Ιστορικό τιμής μετοχής της Altamira Therapeutics Ltd. από 2014 έως 2026
Ετήσια απόδοση τιμής μετοχής
Έτος Απόδοση
2026 (TTM) 0.00%
2025 -8.12%
2024 -93.34%
2023 -95.12%
2022 -83.04%
2021 -50.21%
2020 106.19%
2019 -84.04%
2018 -90.18%
2017 -62.31%
2016 -66.97%
2015 -7.95%
2014 0.00%
Τιμή μετοχής για παρόμοιες εταιρείες ή ανταγωνιστές
Εταιρεία Τιμή μετοχής Μεταβολή 1Έτ% Χώρα
$505.24 29.45%
US
$846.09 29.68%
NL
$731.69 7.13%
CH
$1.07K -6.40%
KR
$251.82 11.25%
BE